Browse > Article
http://dx.doi.org/10.5322/JES.2007.16.2.219

1,3-Dichloro-2-Propanol (1,3-DCP) Induced Cell Damage  

Jeong, Ji-Hak (Department of Biology, College of Natural Sciences, Kyungpook National University)
Sin, Ik-Jae (Department of Nanomedical Engineering, College of Nano Science and Technology, Pusan National University)
Sin, Yeong-Min (Center for Food & Drug Analysis., Busan Regional Food & Drug Administration)
Park, Heung-Jai (School of Environmental Science & Engineering/Institute of Life Environment, Inje University)
An, Won-Gun (Department of Nanomedical Engineering, College of Nano Science and Technology, Pusan National University)
Publication Information
Journal of Environmental Science International / v.16, no.2, 2007 , pp. 219-225 More about this Journal
Abstract
Endocrine disrupting compounds (EDC's) are chemicals that either mimic endogenous hormones interfering with pharmacokinetics or act by other mechanisms. Some endocrine disrupters were reported to be chemical substances that cause apoptosis in cells. A number of reports have indicated that 1,3-DCP, one of the EDC's may act as an endocrine disrupter and also has possible carcinogenic effects. 1,3-DCP, present in commercial protein hydrolysates used for human nutrition, are genotoxic and 1,3-dichloro-2-propanol induced tumors in rats. In the present study, it was investigated whether 1,3-DCP induces ROS generation and apotosis in A549 adenocarcinoma cells. Here we show that 1,3-DCP inhibits the growth of lung cancer cell lines and generates reactive oxygen species (ROS), a major cause of DNA damage and genetic instability, It was investigated that 1,3-DCP increases G1 phase cells after 12 hours, thereafter abruptly draws A549 cells to G0 state after 24 hours by flow cytometric analysis. 1,3-DCP induces p53 and $p21^{Cip1/WAF1}$ activation time- and dose-dependently by 24 hours, while the level $p21^{Cip1/WAF1}$ was decreased after 48 hours. These results suggest that 1,3-DCP, an EDC's generates ROS and regulates genes involved with cell cycle and apoptosis.
Keywords
1,3-Dichloro-2-propanol (1,3-DCP); Endocrine disrupting compounds (EDC's); Apoptosis; ROS; P53; P21;
Citations & Related Records
연도 인용수 순위
  • Reference
1 L'Huillier, N., M. K. Pratten and R. H. Clothier, 2002, The relative embryotoxicity of 1,3-dichloro-2-propanol on primary chick embryonic cells. Toxicol In Vitro., 16(4), 433442   DOI   ScienceOn
2 Talcott, R. E. and J. King, 1984, Mutagenic impurities in 1,3-dichloropropene preparations. J. Natl. Cancer Inst., 72(5), 1113-1116
3 Piasecki, A:., A. Ruge and H. Marquardt, 1990, Malignant transformation of mouse M2fibroblasts by glycerol chlorohydrines contained in protein hydrolysates and commercial food, Arzneirnittelforschung, 40(9), 10541055
4 Shiozaki, T., Y. Mizobata, H. Sugimoto, T. Yoshioka and T. Sugimoto, 1994, Fulminant hepatitis following exposure to dichlorohydrin-report of two cases, Hum. Exp, ToxicoI., 13(4), 267-270   DOI
5 Hahn, H., E. Eder and C. Deininger, 1991, Genotoxicity of 1,3-dichloro-2-propanol in the SOS chromotest and in the Ames test. Elucidation of the genotoxic mechanism, Chern. BioI. Interact., 80(1), 73-88   DOI   ScienceOn
6 Ellis, R. E., J. Y. Yuan and H. R. Horvitz, 1991, Mechanisms and functions of cell death. Annu. Rev. Cell BioI., 7, 663-698   DOI   ScienceOn
7 Shimizu, T., C.X., Cao, RG. Shao and Y. Pommier, 1998, Larnin B phosphorylation by protein kinase calpha and proteolysis during apoptosis in human leukemia HL60 cells. J BioI. Chern., 273(5), 8669-8674   DOI   ScienceOn
8 Katoh, T., J Haratake, S. Nakano, M. Kikuchi, M. Yoshikawa and K. Arashidani, 1998, Dosedependent effects of dichloropropanol on liver histology and lipid peroxidation in rats. Ind. Health, 36(4), 318-323   DOI
9 Martirosyan, A., S. Leonard, X. Shi, B. Griffith, P. Gannett and J Strobl, 2006, Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinoI) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cells, J Pharmacal. Exp. Ther., 317(2), 546-552   DOI   ScienceOn
10 Romano, M. F., R. Avellino, A. Petrella, R. Bisogni, S. Romano and S. Venuta, 2004, Rapamycin inhibits doxorubicin-induced NFkappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells, Eur. J. Cancer, 40(18), 2829-2836   DOI   ScienceOn
11 Choisy-Rossi, C., P. Reisdorf and E. YonishRouach, 1998, Mechanisms of p.53- induced apoptosis: in search of genes which are regulated during p.53-meeliated cell death. Toxico.l Lett., 102-103, 491-496
12 Wang, S. and W. S. El-Deiry, 2004, The p.53 pathway: targets for the development of novel cancer therapeutics. Cancer Treat. Res., 119, 175-187   DOI
13 Roninson, I. B., 2002, Oncogenic functions of tumour suppressor p.2(Wafl/Cipl/ Sdil): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett., 179(1), 1-14   DOI   ScienceOn
14 Dumont, P., M. Burton, Q. M. Chen, E. S. Gonos, C. Frippiat, J.B. Mazarati, F. Eliaers, J. Remade and O. Toussaint, 2000, Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radic. Biol. Med., 28(3), 361-373   DOI   ScienceOn
15 Morisaki, H., A. Ando, Y. Nagata, O. PereiraSmith, J.R. Smith, K Ikeda and M. Nakanishi, 1999, Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cydin D1. Exp. Cell Res., 253(2), 503-510   DOI   ScienceOn
16 Hattangadi, D. K, G. A. DeMasters, T. D. Walker, K R. Jones, X. Di, IF. Newsham and D. A. Gewirtz, 2004, Influence of p.53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. Biochem. Pharmacol., 68(9), 1699-1708   DOI   ScienceOn
17 el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K.W. Kinzler and B. Vogelstein, 1993, WAFl, a potential mediator of p.53 tumor suppression. Cell, 75(4), 817-825   DOI   ScienceOn
18 Green, D. and G. Kroemer, 1998, The central executioners of apoptosis: caspases or mitochondria? Trends Cell BioI., 8(7), 267-271   DOI   ScienceOn
19 Liu, X. M., J. Z. Shao, L. X. Xiang and X. Y. Chen, 2006, Cytotoxic effects and apoptosis induction of atrazine in a grass carp (Ctenopharyngodon idellus) cell line. Environ. Toxicol., 21(1), 80-89   DOI   ScienceOn
20 Chen, T. J, J Y. Jeng, C. W. Lin, C. Y. Wu and Y. C. Chen, 2006, Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells, Toxicology, 223(1-2), 113-126   DOI   ScienceOn
21 Blagosklonny, M. V., 2002, P53: an ubiquitous target of anticancer drugs. Int. J. Cancer, 98(2), 161-166   DOI   ScienceOn
22 Omura, M., M. Hirata, M. Zhao, A. Tanaka and N. Inoue, 1995, Comparative testicular toxicities of two isomers of dichloropropanol, 2,3-dichloro-l-propanol, and 1,3-dichloro-2propanol, and their metabolites alpha-chlorohydrin and epichlorohydrin, and the potent testicular toxicant 1,2-dibromo-3-chloropropane. Bull. Environ. Contam. Toxicol., 55(1), 1-7   DOI
23 Pathak, N. and S. Khandelwal, 2006, Oxidative stress and apoptotic changes in murine splenocytes exposed to cadmium. Toxicology, 220(1), 26-36   DOI   ScienceOn
24 Bargonetti, J and J. J. Manfredi, Multiple roles of the tumor suppressor p.53, Curro Opin, Oncol., 14(1), 86-91
25 Choisy-Rossi, C., P. Reisdorf and E. YonishRouach, 1998, Mechanisms of p.53- induced apoptosis: in search of genes which are regulated during p.53-mediated cell death. Toxicol. Lett., 102-103, 491-496
26 Hansen, R. and M. Oren, 1997, p.53: from inductive signal to cellular effect. Curro Opin. Genet. Dev., 7(1), 46-51   DOI   ScienceOn
27 Soengas, M. S., R. M. Alarcon, H. Yoshida, A. J. Giaccia, R. Hakem, T. W. Mak and S. W. Lowe, 1999, Apaf-1 and caspase-9 in p.53- dependent apoptosis and tumor inhibition. Science, 284(5411), 156-159   DOI   ScienceOn
28 Gao, C. and N. Tsuchida, 1999, Activation of caspases in p.53-induced transactivation-independent apoptosis. Jpn. J. Cancer Res., 90(2), 180-187   DOI
29 Fisher, D. E., 1994, Apoptosis in cancer therapy: crossing the threshold. Cell, 78(4), 539542   DOI   ScienceOn
30 Budavari, S., 1989, The Merck index, Merck, Rahway, 3058pp